Faculty profile

Candice Bjornson

ProfessorDepartment of PediatricsUniversity of Calgary

Research

Read how they describe their research on their University of Calgary profile.

croup treatment and outcomes quality improvement in patient care cystic fibrosis national registry collaborative studies RSV treatment and outcomes

Latest papers

High-quality read-based phasing of cystic fibrosis cohort informs genetic understanding of disease modification.
HGG advances · 2023
Genetic evidence supports the development of SLC26A9 targeting therapies for the treatment of lung disease.
NPJ genomic medicine · 2022
Cystic fibrosis–related diabetes onset can be predicted using biomarkers measured at birth
Genetics in Medicine · 2021

All 14 publications

14 publications.

High-quality read-based phasing of cystic fibrosis cohort informs genetic understanding of disease modification.

Mastromatteo S, Chen A, Gong J, Lin F, Thiruvahindrapuram B, Sung WWL, Whitney J, Wang Z, Patel RV, Keenan K, Halevy A, Panjwani N, Avolio J, Wang C, Côté-Maurais G, Bégin S, Adam D, Brochiero E, Bjornson C, Chilvers M, Price A, Parkins M, van Wylick R, Mateos-Corral D, Hughes D, Smith MJ, Morrison N, Tullis E, Stephenson AL, Wilcox P, Quon BS, Leung WM, Solomon M, Sun L, Ratjen F, Strug LJ

HGG advances2023

DOI: 10.1016/j.xhgg.2022.100156 PMID: 36386424

Genetic evidence supports the development of SLC26A9 targeting therapies for the treatment of lung disease.

Gong J, He G, Wang C, Bartlett C, Panjwani N, Mastromatteo S, Lin F, Keenan K, Avolio J, Halevy A, Shaw M, Esmaeili M, Côté-Maurais G, Adam D, Bégin S, Bjornson C, Chilvers M, Reisman J, Price A, Parkins M, van Wylick R, Berthiaume Y, Bilodeau L, Mateos-Corral D, Hughes D, Smith MJ, Morrison N, Brusky J, Tullis E, Stephenson AL, Quon BS, Wilcox P, Leung WM, Solomon M, Sun L, Brochiero E, Moraes TJ, Gonska T, Ratjen F, Rommens JM, Strug LJ

NPJ genomic medicine2022

DOI: 10.1038/s41525-022-00299-9 PMID: 35396391

Cystic fibrosis–related diabetes onset can be predicted using biomarkers measured at birth

Lin Y-C, Keenan K, Gong J, Panjwani N, Avolio J, Lin F, Adam D, Barrett P, Bégin S, Berthiaume Y

Genetics in Medicine202129 citations

DOI: 10.1038/s41436-020-01073-x

Correction to: Cystic fibrosis–related diabetes onset can be predicted using biomarkers measured at birth

Lin Y-C, Keenan K, Gong J, Panjwani N, Avolio J, Lin F, Adam D, Barrett P, Bégin S, Berthiaume Y

Genetics in Medicine2021

DOI: 10.1038/s41436-021-01281-z

Outcomes of Cystic Fibrosis Screening-Positive Infants With Inconclusive Diagnosis at School Age.

Gonska T, Keenan K, Au J, Dupuis A, Chilvers MA, Burgess C, Bjornson C, Fairservice L, Brusky J, Kherani T, Jober A, Kosteniuk L, Price A, Itterman J, Morgan L, Mateos-Corral D, Hughes D, Donnelly C, Smith MJ, Iqbal S, Arpin J, Reisman J, Hammel J, van Wylick R, Derynck M, Henderson N, Solomon M, Ratjen F

Pediatrics2021

DOI: 10.1542/peds.2021-051740 PMID: 34814176

Immunoreactive trypsinogen levels in newborn screened infants with an inconclusive diagnosis of cystic fibrosis.

Ooi CY, Sutherland R, Castellani C, Keenan K, Boland M, Reisman J, Bjornson C, Chilvers MA, van Wylick R, Kent S, Price A, Mateos-Corral D, Hughes D, Solomon M, Zuberbuhler P, Brusky J, Durie PR, Ratjen F, Gonska T

BMC pediatrics2019

DOI: 10.1186/s12887-019-1756-4 PMID: 31640630

Palivizumab prophylaxis for respiratory syncytial virus in infants with cystic fibrosis: is there a need?

Bjornson C, Chan P, Li A, Paes B, Lanctôt KL, Mitchell I

European Journal of Clinical Microbiology and Infectious Diseases201811 citationsFirst author

DOI: 10.1007/s10096-018-3225-7

Surfactant Dysfunction in ARDS and Bronchiolitis is Repaired with Cyclodextrins.

Al-Saiedy M, Gunasekara L, Green F, Pratt R, Chiu A, Yang A, Dennis J, Pieron C, Bjornson C, Winston B, Amrein M

Military medicine2018

DOI: 10.1093/milmed/usx204 PMID: 29635617

Pulmonary surfactant dysfunction in pediatric cystic fibrosis: Mechanisms and reversal with a lipid-sequestering drug.

Gunasekara L, Al-Saiedy M, Green F, Pratt R, Bjornson C, Yang A, Michael Schoel W, Mitchell I, Brindle M, Montgomery M, Keys E, Dennis J, Shrestha G, Amrein M

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society2017

DOI: 10.1016/j.jcf.2017.04.015 PMID: 28599957

Inconclusive diagnosis of cystic fibrosis after newborn screening.

Ooi CY, Castellani C, Keenan K, Avolio J, Volpi S, Boland M, Kovesi T, Bjornson C, Chilvers MA, Morgan L, van Wylick R, Kent S, Price A, Solomon M, Tam K, Taylor L, Malitt KA, Ratjen F, Durie PR, Gonska T

Pediatrics2015

DOI: 10.1542/peds.2014-2081 PMID: 25963003

Profile data last refreshed on September 27, 2026 from the university directory, publication records and CIHR, NSERC and SSHRC funding.

Something wrong or missing on this profile? Suggest a correction

Candice Bjornson

Research

Latest papers

High-quality read-based phasing of cystic fibrosis cohort informs genetic understanding of disease modification.

Genetic evidence supports the development of SLC26A9 targeting therapies for the treatment of lung disease.

Cystic fibrosis–related diabetes onset can be predicted using biomarkers measured at birth

Correction to: Cystic fibrosis–related diabetes onset can be predicted using biomarkers measured at birth

Outcomes of Cystic Fibrosis Screening-Positive Infants With Inconclusive Diagnosis at School Age.

Immunoreactive trypsinogen levels in newborn screened infants with an inconclusive diagnosis of cystic fibrosis.

Palivizumab prophylaxis for respiratory syncytial virus in infants with cystic fibrosis: is there a need?

Surfactant Dysfunction in ARDS and Bronchiolitis is Repaired with Cyclodextrins.

Pulmonary surfactant dysfunction in pediatric cystic fibrosis: Mechanisms and reversal with a lipid-sequestering drug.

Inconclusive diagnosis of cystic fibrosis after newborn screening.

Frequent collaborators

Felix Ratjen

Lei Sun

Michael Parkins

Tanja Gonska

Mary Jackson

Mary Brindle

Matthias Amrein

Karen Kam

Annie Dupuis

Kelly Russell

Bosco Paes